Ernexa Therapeutics Inc. (ERNA) vs Mustang Bio, Inc. (MBIO)
A side-by-side comparison of Ernexa Therapeutics Inc. and Mustang Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ERNA
Ernexa Therapeutics Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 11:48 AM EDT
Total return — ERNA vs MBIO
growth of $100 · dividends reinvested · last 9yERNA -100.0% (-69.4%/yr)MBIO -100.0% (-65.9%/yr)MBIO compounded faster over this window
ERNA MBIO
ERNA vs MBIO: by the numbers
- •ERNA is the larger company ($4M vs $3M market cap).
Metrics side by side
Valuation
| Metric | ERNA | MBIO |
|---|---|---|
| P/B ratio | 1.26 | 0.46 |
Profitability
| Metric | ERNA | MBIO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -383.03% | -40.20% |
| ROIC | -346.94% | -45.77% |
Growth (annualized)
| Metric | ERNA | MBIO |
|---|---|---|
| Total return CAGR (5Y) | -86.83% | -80.80% |
Frequently asked
- How have ERNA and MBIO total returns compared?
- Over the past 5 years, ERNA delivered -86.83% and MBIO delivered -80.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.